Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Dascena's investors include National Science Foundation, Frazier Healthcare Partners, Longitude Capital, National Institutes of Health, Euclidean Capital.
Dascena is headquartered in Houston, United States.
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Dascena is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dascena — Funding & Investors." VCBacked, March 29, 2022, https://www.vcbacked.co/company/dascena. Accessed July 20, 2026.
VCBacked. (2022). Dascena — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/dascena
{{cite web |title=Dascena — Funding & Investors |url=https://www.vcbacked.co/company/dascena |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated